Health plans reasonably believe that they can be a primary source for aiding patients in managing their health and health care. An article in Health Affairs describes UnitedHealth Group’s efforts towards this end. (HA Article) The company has identified several critical factors in engagement and offers them both to health plan members but also to the health plan used by its own employees. Health plans have some advantages in encouraging patient engagement; they have large and near real-time sources of data, including claims data and they have a relationship with patients that crosses all providers of care. Payers can use the data to help identify potential gaps in care and encourage both patients and their physicians to address those gaps. UHG has focused on messaging that is most likely to reach patients–mail, email, text, etc; based on the patient’s own preferences. The messaging can also be segmented by demographics or other characteristics. A program using this messaging called HealtheNotes closed 64% more medical management gaps than usual methods. The company has also developed programs to encouraged shared decision-making in nine preference sensitive conditions. This program purportedly saves about $11,000 per treatment, apparently because patients tend to choose more conservative treatments when they are activated and involved. For its own employees UHG uses a premium reduction incentive that scales depending on the level of engagement and results that an employee displays. A large number of employees have participated and achieved rewards, with a savings to UHG of $107 million compared to industry average health care cost increases. The UHG program appears to be successful but a more comprehensive research analysis that looks both at health outcomes and net savings would be useful.
Incentives and Patient Engagement
By Kevin RocheAugust 15, 2013Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
CVS has finalized its $10.6 billion buyout of Oak Street health, which operates primary care centers for Medicare members. People may think CVS is a drug store company, but it...
May 4, 2023
Option Care, a large home health care provider is acquiring Amedisys, another large player in that market, for $3.6 billion, as consolidation ramps up across health care, likely meaning higher...
May 4, 2023
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
June 1, 2023
More Examples of Why Health Care Costs Are High
A couple of pieces on prices for services in different treatment settings and physician compensation…
May 31, 2023
Medical Inflation is Real
A long-running report on the health care costs of a typical family reveals higher growth…
May 31, 2023
The Damage from the Epidemic Response
A great paper summarizes the harms from the epidemic response.